Authors: Paganelli, G Zoboli, S Cremonesi, M Bodei, L Ferrari, M Grana, C Bartolomei, M Orsi, F De Cicco, C Maacke, HR Chinol, M de Braud, F

Citation: G. Paganelli et al., Receptor-mediated radiotherapy with Y-90-DOTA-D-Phe(1)-Tyr(3)-octreotide, EUR J NUCL, 28(4), 2001, pp. 426-434

Authors: Mariani, G Ferdeghini, M Augeri, C Villa, G Taddei, GZ Scopinaro, G Boni, G Bodei, L Rabitti, C Molinari, E Bianchi, R

Citation: G. Mariani et al., Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer, CANC BIO R, 15(2), 2000, pp. 211-217

Authors: Ricci, S Antonuzzo, A Galli, L Ferdeghini, M Bodei, L Orlandini, C Conte, PF

Citation: S. Ricci et al., Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide, ANN ONCOL, 11(9), 2000, pp. 1127-1130

Authors: Mariani, G Bodei, L Adelstein, SJ Kassis, AI

Citation: G. Mariani et al., Emerging roles for radiometabolic therapy of tumors based on Auger electron emission, J NUCL MED, 41(9), 2000, pp. 1519-1521

Authors: Lazzeri, E Manca, M Molea, N Marchetti, S Consoli, V Bodei, L Bianchi, R Chinol, M Paganelli, G Mariani, G

Citation: E. Lazzeri et al., Clinical validation of the avidin/indium-111 biotin approach for imaging infection inflammation in orthopaedic patients, EUR J NUCL, 26(6), 1999, pp. 606-614